makkhorn, 1 month ago to MandelaEffect THX, JOE! FTC Challenging JUNK PATENTS by Big Pharma PASS THE NEWS ON. #thanksJoe #Your Job is to TALK IT UP ‼️ #big Pharma #pricefixing #monopoly #legal #junkPatents #asthmaInhalers #news #drugs #economy On April 30, Fed Trade Commission (FTC) challenged more than 300 junk patent drug listings: diabetes, asthma, (COPD) and Ozempic. Bogus patent listings prevent generic drugs to come to market, keeping prices high. In Nov. the FTC successfully challenged junk patents on asthma inhalers, reducing their price to $35. https://substack.com/app-link/post?publication_id=20533&post_id=144352111&utm_source=post-email-title&utm_campaign=email-post-title&isFreemail=true&r=eo2d1&token=eyJ1c2VyX2lkIjoyNDYzNzQyOSwicG9zdF9pZCI6MTQ0MzUyMTExLCJpYXQiOjE3MTQ5NzI1MzQsImV4cCI6MTcxNzU2NDUzNCwiaXNzIjoicHViLTIwNTMzIiwic3ViIjoicG9zdC1yZWFjdGlvbiJ9.wOwg1ZuWwh0gy36k-pKBLtKiKjvXitBLeIkz8BYem8g
THX, JOE! FTC Challenging JUNK PATENTS by Big Pharma
PASS THE NEWS ON. #thanksJoe
#Your Job is to TALK IT UP ‼️
#big Pharma #pricefixing #monopoly #legal #junkPatents #asthmaInhalers #news #drugs #economy
On April 30, Fed Trade Commission (FTC) challenged more than 300 junk patent drug listings: diabetes, asthma, (COPD) and Ozempic.
Bogus patent listings prevent generic drugs to come to market, keeping prices high.
In Nov. the FTC successfully challenged junk patents on asthma inhalers, reducing their price to $35. https://substack.com/app-link/post?publication_id=20533&post_id=144352111&utm_source=post-email-title&utm_campaign=email-post-title&isFreemail=true&r=eo2d1&token=eyJ1c2VyX2lkIjoyNDYzNzQyOSwicG9zdF9pZCI6MTQ0MzUyMTExLCJpYXQiOjE3MTQ5NzI1MzQsImV4cCI6MTcxNzU2NDUzNCwiaXNzIjoicHViLTIwNTMzIiwic3ViIjoicG9zdC1yZWFjdGlvbiJ9.wOwg1ZuWwh0gy36k-pKBLtKiKjvXitBLeIkz8BYem8g